NCT04221945 2026-02-20KEYNOTE-A18Merck Sharp & Dohme LLCPhase 3 Completed1,060 enrolled 30 charts 1 FDA
NCT05570422 2025-09-11A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01Kortuc, Inc.Phase 1 Not yet recruiting70 enrolled
NCT01851772 2021-01-12Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical CancerXoft, Inc.Phase NA Completed3 enrolled 6 charts
NCT00191100 2009-08-11Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the CervixEli Lilly and CompanyPhase 3 Completed515 enrolled 20 charts